These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31529618)

  • 21. The effect of incident tuberculosis on immunological response of HIV patients on highly active anti-retroviral therapy at the university of Gondar hospital, northwest Ethiopia: a retrospective follow-up study.
    Assefa A; Gelaw B; Getnet G; Yitayew G
    BMC Infect Dis; 2014 Aug; 14():468. PubMed ID: 25164855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trend of tuberculosis case notifications and their determinants in Africa and South-East Asia during 2000-2018: a longitudinal analysis of national data from 58 countries.
    Boah M; Adampah T; Jin B; Wang W; Wang K
    Infect Dis (Lond); 2020 Aug; 52(8):538-546. PubMed ID: 32431192
    [No Abstract]   [Full Text] [Related]  

  • 23. Incidence of Tuberculosis Among HIV-Positive Individuals Initiating Antiretroviral Treatment at Higher CD4 Counts in the HPTN 071 (PopART) Trial in South Africa.
    Bock P; Jennings K; Vermaak R; Cox H; Meintjes G; Fatti G; Kruger J; De Azevedo V; Maschilla L; Louis F; Gunst C; Grobbelaar N; Dunbar R; Limbada M; Floyd S; Grimwood A; Ayles H; Hayes R; Fidler S; Beyers N
    J Acquir Immune Defic Syndr; 2018 Jan; 77(1):93-101. PubMed ID: 29016524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy.
    Liu E; Makubi A; Drain P; Spiegelman D; Sando D; Li N; Chalamilla G; Sudfeld CR; Hertzmark E; Fawzi WW
    AIDS; 2015 Jul; 29(11):1391-9. PubMed ID: 26091295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.
    Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD
    PLoS One; 2012; 7(3):e34156. PubMed ID: 22479548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The scale-up of antiretroviral therapy coverage was strongly associated with the declining tuberculosis morbidity in Africa during 2000-2018.
    Boah M; Jin B; Adampah T; Wang W; Wang K
    Public Health; 2021 Feb; 191():48-54. PubMed ID: 33508661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased uptake of tuberculosis preventive therapy (TPT) among people living with HIV following the 100-days accelerated campaign: A retrospective review of routinely collected data at six urban public health facilities in Uganda.
    Musaazi J; Sekaggya-Wiltshire C; Okoboi S; Zawedde-Muyanja S; Senkoro M; Kalema N; Kavuma P; Namuwenge PM; Manabe YC; Castelnuovo B; Kiragga A
    PLoS One; 2023; 18(2):e0268935. PubMed ID: 36821550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.
    Bwire R; Nagelkerke NJ; Borgdorff MW
    Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models.
    Pretorius C; Menzies NA; Chindelevitch L; Cohen T; Cori A; Eaton JW; Fraser C; Gopalappa C; Hallett TB; Salomon JA; Stover J; White RG; Dodd PJ
    AIDS; 2014 Jan; 28 Suppl 1():S25-34. PubMed ID: 24468944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tuberculosis in human immunodeficiency virus infected Ugandan children starting on antiretroviral therapy.
    Bakeera-Kitaka S; Conesa-Botella A; Dhabangi A; Maganda A; Kekitiinwa A; Colebunders R; Boulware DR
    Int J Tuberc Lung Dis; 2011 Aug; 15(8):1082-6. PubMed ID: 21740672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in the timing of antiretroviral therapy initiation in HIV-infected patients with tuberculosis in Uganda: a study of the diffusion of evidence into practice in the global response to HIV/AIDS.
    Vijayan T; Semitala FC; Matsiko N; Elyanu P; Namusobya J; Havlir DV; Kamya M; Geng EH
    Clin Infect Dis; 2013 Dec; 57(12):1766-72. PubMed ID: 24065326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting.
    Hermans SM; Manabe YC; Kiragga AN; Hoepelman AI; Lange JM; van Leth F
    Antivir Ther; 2013; 18(4):615-22. PubMed ID: 23423604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiretroviral treatment-associated tuberculosis in a prospective cohort of HIV-infected patients starting ART.
    Worodria W; Massinga-Loembe M; Mayanja-Kizza H; Namaganda J; Kambugu A; Manabe YC; Kestens L; Colebunders R
    Clin Dev Immunol; 2011; 2011():758350. PubMed ID: 21197091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda.
    Moore D; Liechty C; Ekwaru P; Were W; Mwima G; Solberg P; Rutherford G; Mermin J
    AIDS; 2007 Mar; 21(6):713-9. PubMed ID: 17413692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy.
    Worodria W; Massinga-Loembe M; Mazakpwe D; Luzinda K; Menten J; Van Leth F; Mayanja-Kizza H; Kestens L; Mugerwa RD; Reiss P; Colebunders R;
    J Acquir Immune Defic Syndr; 2011 Sep; 58(1):32-7. PubMed ID: 21654499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.
    Lawn SD; Myer L; Bekker LG; Wood R
    AIDS; 2006 Aug; 20(12):1605-12. PubMed ID: 16868441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and mortality of tuberculosis before and after initiation of antiretroviral therapy: an HIV cohort study in India.
    Alvarez-Uria G; Pakam R; Midde M; Naik PK
    J Int AIDS Soc; 2014; 17(1):19251. PubMed ID: 25499123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of tuberculosis and the need of prophylactic treatment in persons living with HIV in Stockholm during the era of anti-retroviral therapy 1996-2013.
    Norrby M; Wannheden C; Ekström AM; Berggren I; Lindquist L
    Infect Dis (Lond); 2018; 50(11-12):807-816. PubMed ID: 30362392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.
    Crook AM; Turkova A; Musiime V; Bwakura-Dangarembizi M; Bakeera-Kitaka S; Nahirya-Ntege P; Thomason M; Mugyenyi P; Musoke P; Kekitiinwa A; Munderi P; Nathoo K; Prendergast AJ; Walker AS; Gibb DM;
    BMC Med; 2016 Mar; 14():50. PubMed ID: 27004529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of antiretroviral treatment on mortality trends of HIV-positive adults in rural Uganda: a longitudinal population-based study, 1999-2009.
    Kasamba I; Baisley K; Mayanja BN; Maher D; Grosskurth H
    Trop Med Int Health; 2012 Aug; 17(8):e66-73. PubMed ID: 22943381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.